Literature DB >> 23671283

Role of cystatin C in amyloid precursor protein-induced proliferation of neural stem/progenitor cells.

Yanling Hu1, Amos C Hung, Hao Cui, Edgar Dawkins, Marta Bolós, Lisa Foa, Kaylene M Young, David H Small.   

Abstract

The amyloid precursor protein (APP) is well studied for its role in Alzheimer disease. However, little is known about its normal function. In this study, we examined the role of APP in neural stem/progenitor cell (NSPC) proliferation. NSPCs derived from APP-overexpressing Tg2576 transgenic mice proliferated more rapidly than NSPCs from the corresponding background strain (C57Bl/6xSJL) wild-type mice. In contrast, NSPCs from APP knock-out (APP-KO) mice had reduced proliferation rates when compared with NSPCs from the corresponding background strain (C57Bl/6). A secreted factor, identified as cystatin C, was found to be responsible for this effect. Levels of cystatin C were higher in the Tg2576 conditioned medium and lower in the APP-KO conditioned medium. Furthermore, immunodepletion of cystatin C from the conditioned medium completely removed the ability of the conditioned medium to increase NSPC proliferation. The results demonstrate that APP expression stimulates NSPC proliferation and that this effect is mediated via an increase in cystatin C secretion.

Entities:  

Keywords:  Amyloid; Amyloid Precursor Protein; Cystatin C; Neural Stem Cell; Neurogenesis; Proliferation

Mesh:

Substances:

Year:  2013        PMID: 23671283      PMCID: PMC3696661          DOI: 10.1074/jbc.M112.443671

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

Review 1.  Microenvironmental determinants of adult neural stem cell proliferation and lineage commitment in the healthy and injured central nervous system.

Authors:  Emmanuel Moyse; Stéphanie Segura; Oliver Liard; Stéphanie Mahaut; Naguib Mechawar
Journal:  Curr Stem Cell Res Ther       Date:  2008-09       Impact factor: 3.828

2.  Amyloid precursor protein is required for convergent-extension movements during Zebrafish development.

Authors:  Powrnima Joshi; Jennifer O Liang; Kristine DiMonte; John Sullivan; Sanjay W Pimplikar
Journal:  Dev Biol       Date:  2009-08-04       Impact factor: 3.582

Review 3.  Molecular pathology of head trauma: altered beta APP metabolism and the aetiology of Alzheimer's disease.

Authors:  S M Gentleman; D I Graham; G W Roberts
Journal:  Prog Brain Res       Date:  1993       Impact factor: 2.453

4.  FGF-2-responsive neural stem cell proliferation requires CCg, a novel autocrine/paracrine cofactor.

Authors:  P Taupin; J Ray; W H Fischer; S T Suhr; K Hakansson; A Grubb; F H Gage
Journal:  Neuron       Date:  2000-11       Impact factor: 17.173

5.  Amyloid precursor protein and ubiquitin immunoreactivity in dystrophic axons is not unique to Alzheimer's disease.

Authors:  E Cochran; B Bacci; Y Chen; A Patton; P Gambetti; L Autilio-Gambetti
Journal:  Am J Pathol       Date:  1991-09       Impact factor: 4.307

Review 6.  Regulation of APP cleavage by alpha-, beta- and gamma-secretases.

Authors:  J Nunan; D H Small
Journal:  FEBS Lett       Date:  2000-10-13       Impact factor: 4.124

7.  A critical function for beta-amyloid precursor protein in neuronal migration revealed by in utero RNA interference.

Authors:  Tracy L Young-Pearse; Jilin Bai; Rui Chang; Jessica B Zheng; Joseph J LoTurco; Dennis J Selkoe
Journal:  J Neurosci       Date:  2007-12-26       Impact factor: 6.167

8.  Association and release of the amyloid protein precursor of Alzheimer's disease from chick brain extracellular matrix.

Authors:  D H Small; V Nurcombe; R Moir; S Michaelson; D Monard; K Beyreuther; C L Masters
Journal:  J Neurosci       Date:  1992-11       Impact factor: 6.167

9.  Increased neurogenesis in young transgenic mice overexpressing human APP(Sw, Ind).

Authors:  Miguel A López-Toledano; Michael L Shelanski
Journal:  J Alzheimers Dis       Date:  2007-11       Impact factor: 4.472

10.  Transgenic APP expression during postnatal development causes persistent locomotor hyperactivity in the adult.

Authors:  Shaefali P Rodgers; Heather A Born; Pritam Das; Joanna L Jankowsky
Journal:  Mol Neurodegener       Date:  2012-06-18       Impact factor: 14.195

View more
  10 in total

1.  Cystatin C prevents neuronal loss and behavioral deficits via the endosomal pathway in a mouse model of down syndrome.

Authors:  Gurjinder Kaur; Sebastien A Gauthier; Rocio Perez-Gonzalez; Monika Pawlik; Amol Bikram Singh; Benjamin Cosby; Panaiyur S Mohan; John F Smiley; Efrat Levy
Journal:  Neurobiol Dis       Date:  2018-09-01       Impact factor: 5.996

2.  Ovocystatin Induced Changes in Expression of Alzheimer's Disease Relevant Proteins in APP/PS1 Transgenic Mice.

Authors:  Bartlomiej Stanczykiewicz; Jakub Gburek; Maria Rutkowska; Marta Lemieszewska; Krzysztof Gołąb; Katarzyna Juszczyńska; Aleksandra Piotrowska; Tadeusz Trziszka; Piotr Dzięgiel; Marzenna Podhorska-Okołów; Agnieszka Zabłocka; Joanna Rymaszewska
Journal:  J Clin Med       Date:  2022-04-23       Impact factor: 4.964

3.  Neurogenin 2 mediates amyloid-β precursor protein-stimulated neurogenesis.

Authors:  Marta Bolós; Yanling Hu; Kaylene M Young; Lisa Foa; David H Small
Journal:  J Biol Chem       Date:  2014-09-12       Impact factor: 5.157

Review 4.  Insights into the physiological function of the β-amyloid precursor protein: beyond Alzheimer's disease.

Authors:  Edgar Dawkins; David H Small
Journal:  J Neurochem       Date:  2014-03-07       Impact factor: 5.372

Review 5.  Multifaceted Roles of Metzincins in CNS Physiology and Pathology: From Synaptic Plasticity and Cognition to Neurodegenerative Disorders.

Authors:  Patrycja Brzdak; Daria Nowak; Grzegorz Wiera; Jerzy W Mozrzymas
Journal:  Front Cell Neurosci       Date:  2017-06-30       Impact factor: 5.505

6.  The neurofilament derived-peptide NFL-TBS.40-63 enters in-vitro in human neural stem cells and increases their differentiation.

Authors:  Kristell Barreau; Claudia Montero-Menei; Joël Eyer
Journal:  PLoS One       Date:  2018-08-09       Impact factor: 3.240

7.  Amyloid Precursor Protein (APP) Controls the Expression of the Transcriptional Activator Neuronal PAS Domain Protein 4 (NPAS4) and Synaptic GABA Release.

Authors:  Rémi Opsomer; Sabrina Contino; Florian Perrin; Roberta Gualdani; Bernadette Tasiaux; Pierre Doyen; Maxime Vergouts; Céline Vrancx; Anna Doshina; Nathalie Pierrot; Jean-Noël Octave; Philippe Gailly; Serena Stanga; Pascal Kienlen-Campard
Journal:  eNeuro       Date:  2020-05-28

Review 8.  Cystatin C is a disease-associated protein subject to multiple regulation.

Authors:  Yuekang Xu; Ying Ding; Xinchen Li; Xiaobing Wu
Journal:  Immunol Cell Biol       Date:  2015-02-03       Impact factor: 5.126

9.  Prognostic Value of Pretreatment Serum Cystatin C Level in Nasopharyngeal Carcinoma Patients in the Intensity-modulated Radiotherapy Era.

Authors:  Xi-Rong Tan; Sheng-Yan Huang; Sha Gong; Yang Chen; Xiao-Jing Yang; Qing-Mei He; Shi-Wei He; Na Liu; Ying-Qing Li
Journal:  Onco Targets Ther       Date:  2021-01-06       Impact factor: 4.147

10.  Regulation of global gene expression and cell proliferation by APP.

Authors:  Yili Wu; Si Zhang; Qin Xu; Haiyan Zou; Weihui Zhou; Fang Cai; Tingyu Li; Weihong Song
Journal:  Sci Rep       Date:  2016-03-03       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.